218
Participants
Start Date
March 31, 2012
Primary Completion Date
November 30, 2014
Study Completion Date
November 30, 2014
Peginterferon Lambda-1a (BMS-914143)
Observational study - No Intervention \[subjects were previously treated with Peginterferon Lambda-1a (BMS-914143)\]
Local Institution, Vienna
Local Institution, Buenos Aires
Local Institution, Buenos Aires
Local Institution, Buenos Aires
Local Institution, Buenos Aires
Local Institution, Rosario
Local Institution, Darlinghurst
Local Institution, Randwick
Local Institution, Camperdown
Local Institution, Sydney
Local Institution, Westmead
Local Institution, Leuven
Local Institution, Melbourne
Local Institution, Parkville
Local Institution, Heidelberg
Local Institution, Liège
Local Institution, Herston
Local Institution, Woolloongabba
Local Institution, Greenslopes
Local Institution, Adelaide
Local Institution, Mar del Plata
Local Institution, Créteil
Local Institution, Athens
Local Institution, Milan
Local Institution, Milan
Local Institution, Hamburg
Metropolitan Research, Annandale
Duke University Medical Center, Durham
Local Institution, Novara
Gastrointestinal Specialists Of Georgia, Marietta
Local Institution, Bucharest
Orlando Immunology Center, Orlando
Local Institution, Pessac
Local Institution, Montpellier
Local Institution, Guadalajara
Consultants For Clinical Research, Cincinnati
Local Institution, Valencia
Henry Ford Health System, Detroit
Local Institution, Florence
Local Institution, Bucharest
Local Institution, Thessaloniki
Mayo Clinic, Rochester
Local Institution, Cisanello (pisa)
Local Institution, Heidelberg
Local Institution, Paris
Local Institution, Paris
Texas Clinical Research Institute, Arlington
St. Luke'S Episcopal Hospital - Baylor College Of Medicine, Houston
University Of Texas Health Science Center At Houston, Houston
Va Medical Center (151), Houston
Texas Liver Institute, San Antonio
Local Institution, Napoli
Clinical Research Centers Of America, Murray
Local Institution, Auckland
Scripps Clinic, La Jolla
Local Institution, Clichy
The Queen'S Medical Center, Honolulu
Virginia Mason Medical Center, Seattle
Local Institution, Iași
Yale University School Of Medicine, New Haven
Local Institution, Fitzroy
Toronto Digestive Disease Associates, Inc., Vaughan
Local Institution, Hus
Local Institution, Nice
Local Institution, Viale Del Policlinico, 155
Local Institution, Amsterdam
Local Institution, Leiden
Local Institution, Bialystok
Local Institution, Krakow
Local Institution, Wroclaw
Local Institution, San Juan
Local Institution, Timișoara
Local Institution, Busan
Local Institution, Barcelona
Local Institution, Barcelona
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY